Details for New Drug Application (NDA): 208797
✉ Email this page to a colleague
The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 208797
Tradename: | PYRIDOSTIGMINE BROMIDE |
Applicant: | Rising |
Ingredient: | pyridostigmine bromide |
Patents: | 0 |
Pharmacology for NDA: 208797
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 208797
Suppliers and Packaging for NDA: 208797
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 208797 | ANDA | Rising Pharma Holdings, Inc. | 16571-833 | 16571-833-16 | 473 mL in 1 BOTTLE, PLASTIC (16571-833-16) |
PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 208797 | ANDA | Apnar Pharma LP | 24689-104 | 24689-104-01 | 473 mL in 1 BOTTLE, PLASTIC (24689-104-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SYRUP;ORAL | Strength | 60MG/5ML | ||||
Approval Date: | Jan 9, 2020 | TE: | AA | RLD: | No |
Complete Access Available with Subscription